Aaron Sandoski, Norwich Ventures
Akintunde (Tunde) Bello, Pfizer
Alex DeWinter, Mohr Davidow Ventures
Andrey Zarur, Kodiak Venture Partners
Anne DeGheest, MedStars
Antoun Nabhan, Onyx Pharmaceuticals
Anu Sharma, Siemens
Armen Shanafelt, Lilly Ventures
Avi Spier, The Genomics Institute of the Novartis
Research Foundation
Bob Molinari, MedStars
Brad Webb, Claremont Creek Ventures
Cal Huntzinger, Varian
Casper DeClerq, Norwest Partners
Catherine Mohr, Intuitive Surgical
Chris Behrenbruch, ImaginAb
Christopher Conway, Albany Molecular Research,
Inc. (AMRI)
Dalton Einhorn, Johnson & Johnson Development Corp
Dan Watkins, DFJ Mercury
David Hanzel, X/Seed Capital
David Heimbrook, SAIC - Frederick, Inc.
Dennis Fujii, Bracco Research USA
Desmond Raitt, Bay Biotech Consulting
Diego Miralles, Janssen
Douglas Kawahara, DJK BioConsult
Elise Brownell, ZephyrBiotech, LLC
Eric Schloesser, Appleseed Innovations
Jill Carroll, GlaxoSmithKline/SR One
Karl Handelsman, CMEA
Klaus Wagner, Genentech
Kristen Schmiedehausen, Medical Strategy Consulting
Linda Mulcahy, Johnson & Johnson Pharmaceuticals
Mara Aspinall, Ventana Medical Systems
Mark Benedyk, Rila Partners
Martin Eglitis, Blazing Star Pharma Advisors
Mary Haak-Frendscho, Takeda
Melinda Richter, Prescience International
Michael Vasconcelles, Sanofi
Mohit Trikha, TriPhase Accelorator
Nathan Sanburn, Lilly
Neela Patel, Abbott
Nola Masterson, Science Futures, Inc.
Peter Thompson, Strategicon Partners
Rekha Hemrajani, Ravinia Consulting
Rick Harkins, Bayer
Robert Balderas, BD Biosciences
Robert Weisskoff, Fidelity Biosciences
Russ Lebovitz, DFJ Mercury
Scott Iyama, Orrick
Shahram Hejazi, BioAdvance
Steve Bartz, Merck
Steve Fawell, Merck Research Laboratories
Sylvaine Cases, Sanofi-aventis
Thorsten Melcher, Centella Therapeutics
Tony Bahinski, Wyss Institute for Biologically Inspired Engineering